Cargando…

Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics

Multidrug-resistant bacteria pose a tremendous challenge to public health worldwide. Many bacteria resistant to last-resort antibiotics due to antibiotic misuse have been recently reported, which may give rise to serious infections without effective treatment. Therefore, it is imperative to develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zeyu, Zhang, Xiaotuan, Yao, Zhuocheng, Han, Yijia, Ye, Jianzhong, Zhang, Yi, Chen, Lijiang, Shen, Mo, Zhou, Tieli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286717/ https://www.ncbi.nlm.nih.gov/pubmed/37017551 http://dx.doi.org/10.1128/msphere.00549-22

Ejemplares similares

Thymol Increases Sensitivity of Clinical Col-R Gram-Negative Bacteria to Colistin
por: Yao, Zhuocheng, et al.
Publicado: (2022)

A potential strategy against clinical carbapenem-resistant Enterobacteriaceae: antimicrobial activity study of sweetener-decorated gold nanoparticles in vitro and in vivo
por: Liu, Haifeng, et al.
Publicado: (2023)

Bacteria Broadly-Resistant to Last Resort Antibiotics Detected in Commercial Chicken Farms
por: Jochum, Jared M., et al.
Publicado: (2021)

Flufenamic Acid, a Promising Agent for the Sensitization of Colistin-Resistant Gram-Negative Bacteria to Colistin
por: Zhang, Yi, et al.
Publicado: (2023)

The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria
por: Tang, Miran, et al.
Publicado: (2023)

Safe doubling of ventilator capacity: a last resort proposal for last resorts
por: Chase, J. Geoffrey, et al.
Publicado: (2020)

Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort
por: Ledger, Elizabeth V. K., et al.
Publicado: (2022)

Raman-Based Antimicrobial Susceptibility Testing on Antibiotics of Last Resort
por: Xiao, Zhirou, et al.
Publicado: (2023)

Debt Relief as a Last Resort for the Lender of Last Resort?: Monetary Financing — Doing It Right
por: Hansen, Arne, et al.
Publicado: (2021)

Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo
por: Huang, Zeyu, et al.
Publicado: (2023)

Last resort: psychosurgery and the limits of medicine
por: Brown, Edward M
Publicado: (1999)

Daptomycin, a last-resort antibiotic, binds ribosomal protein S19 in humans
por: Gotsbacher, Michael P., et al.
Publicado: (2017)

Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions
por: Mohapatra, Saswat S, et al.
Publicado: (2021)

The Capsule Increases Susceptibility to Last-Resort Polymyxins, but Not to Other Antibiotics, in Klebsiella pneumoniae
por: D’Angelo, Francesca, et al.
Publicado: (2023)

Study of Combined Effect of Bacteriophage vB3530 and Chlorhexidine on the Inactivation of Pseudomonas aeruginosa
por: Liu, Yan, et al.
Publicado: (2023)

Editorial: New Insights Into the Transmission Dynamics and Control of Antimicrobial Resistance to Last-Resort Antibiotics
por: Ling, Zhuoren, et al.
Publicado: (2022)

Commentary: The time for last-resort measures—be prepared
por: Martin, Elisabeth, et al.
Publicado: (2020)

Surgery for Crohn’s disease: upfront or last resort?
por: Ahmed Ali, U, et al.
Publicado: (2022)

When Combined with Pentamidine, Originally Ineffective Linezolid Becomes Active in Carbapenem-Resistant Enterobacteriaceae
por: Tang, Miran, et al.
Publicado: (2023)

Last Resort Antibiotics Costs and Reimbursement Analysis of Real-Life ICU Patients with Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Germany
por: Jeck, Julia, et al.
Publicado: (2022)

In-Patient Treatment: Should It Become a Last Resort?
por: Bosanquet, Marion F.
Publicado: (1963)

Fifteen Years of India’s NREGA: Employer of the Last Resort?
por: Narayan, Swati
Publicado: (2022)

The last resort: Workplace bullying and the consequences of changing jobs
por: Rosander, Michael, et al.
Publicado: (2022)

New Chitosan-Grafted Thymol Coated on Gold Nanoparticles for Control of Cariogenic Bacteria in the Oral Cavity
por: Chittratan, Pakawat, et al.
Publicado: (2022)

The Antibacterial Activity of Kaempferol Combined with Colistin against Colistin-Resistant Gram-Negative Bacteria
por: Zhou, Huijing, et al.
Publicado: (2022)

Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability
por: Kong, Jingchun, et al.
Publicado: (2023)

In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates
por: Zeng, Weiliang, et al.
Publicado: (2022)

Last resort antibiotherapy in sepsis with MDR bacteria, one possible solution in a critical patient (case report)
por: Iovănescu, Doina, et al.
Publicado: (2013)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Ferrate (VI) Oxidation Is an Effective and Safe Way to Degrade Residual Colistin - a Last Resort Antibiotic - in Wastewater
por: Wang, Liqi, et al.
Publicado: (2021)

Pre-existing chromosomal polymorphisms in pathogenic E. coli potentiate the evolution of resistance to a last-resort antibiotic
por: Jangir, Pramod K, et al.
Publicado: (2022)

Symes on Thymol and Thymol Camphor
Publicado: (1879)

Synergistic Activity of Thymol with Commercial Antibiotics against Critical and High WHO Priority Pathogenic Bacteria
por: Gan, Cristina, et al.
Publicado: (2023)

Phage resistance formation and fitness costs of hypervirulent Klebsiella pneumoniae mediated by K2 capsule-specific phage and the corresponding mechanisms
por: Tang, Miran, et al.
Publicado: (2023)

Subtotal Gastrectomy as “Last Resort” Consideration in the Management of Refractory Rumination Syndrome
por: Cooper, Chad J., et al.
Publicado: (2014)

Phenytoin as a last‐resort treatment in SCN8A encephalopathy
por: Braakman, Hilde M., et al.
Publicado: (2017)

Flow diversion covering the M1 origin as a last resort
por: Lin, Li-Mei, et al.
Publicado: (2018)

Felbamate for pediatric epilepsy—should we keep on using it as the last resort?
por: Rabinowicz, Shira, et al.
Publicado: (2022)

Current State of Resistance to Antibiotics of Last-Resort in South Africa: A Review from a Public Health Perspective
por: Osei Sekyere, John
Publicado: (2016)

Phosphorus stress induces the synthesis of novel glycolipids in Pseudomonas aeruginosa that confer protection against a last-resort antibiotic
por: Jones, Rebekah A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6r4iq8sotm3pq66abcjar0vtaa